A Trial on Prophylactic Clipping to Prevent Post-polypectomy Bleeding After Colonoscopy in Direct Oral Anticoagulant Users
Recruiting now · Not applicable
Conditions studied: Post Polypectomy Bleeding
In brief
The investigators hypothesize that prophylactic clipping after colonoscopic polypectomy can reduce risk of delayed PPB among DOAC users. The investigators also hypothesize that pre-endoscopy drug level can predict the risk of hemorrhagic complications after the procedure.
Key facts
- Study ID
- NCT05169242
- Run by
- Chinese University of Hong Kong
- People needed
- 584
- Starts
- 2021-12-15
- Expected to finish
- 2024-12-31
- Last updated by the study team
- 2024-08-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- They are active users of any DOAC
- They require elective colonoscopy for colorectal cancer screening, polyp surveillance, or investigation of symptoms such as anemia or past gastrointestinal bleeding
- Aged 18 years old or above;
- Written informed consent obtained.
You may not qualify if…
- Absolute contraindications to colonoscopy
- Any medical conditions precluding interruption of DOAC for procedure
- Any medical conditions requiring concomitant uninterrupted dual antiplatelet drugs (single antiplatelet drug users will not be excluded)
- Active gastrointestinal bleeding
- Clinically significant bleeding tendency (decompensated cirrhosis or severe thrombocytopenia)
- Severe renal impairment (defined as creatinine clearance < 15 ml/min)
- Pregnancy or lactation;
- Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above)
- Unable to obtain informed consent
Where it is running
- Prince of Wales Hospital — Shatin, New Territories, Hong Kong (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.